Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array.

Nowak RG, Ambulos NP, Schumaker LM, Mathias TJ, White RA, Troyer J, Wells D, Charurat ME, Bentzen SM, Cullen KJ.

Virol J. 2017 Jun 13;14(1):112. doi: 10.1186/s12985-017-0771-z.

2.

Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria.

Oga EA, Schumaker LM, Alabi BS, Obaseki D, Umana A, Bassey IA, Ebughe G, Oluwole O, Akeredolu T, Adebamowo SN, Dakum P, Cullen K, Adebamowo CA.

PLoS One. 2016 Apr 6;11(4):e0152828. doi: 10.1371/journal.pone.0152828. eCollection 2016.

3.

Next-Generation Sequencing-Based HPV Genotyping Assay Validated in Formalin-Fixed, Paraffin-Embedded Oropharyngeal and Cervical Cancer Specimens.

Ambulos NP Jr, Schumaker LM, Mathias TJ, White R, Troyer J, Wells D, Cullen KJ.

J Biomol Tech. 2016 Jul;27(2):46-52. doi: 10.7171/jbt.16-2702-004. Epub 2016 Mar 7.

4.

Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer.

Liu SZ, Zandberg DP, Schumaker LM, Papadimitriou JC, Cullen KJ.

Oral Oncol. 2015 Sep;51(9):862-9. doi: 10.1016/j.oraloncology.2015.06.014. Epub 2015 Jul 13.

PMID:
26183400
5.

A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN).

Zandberg DP, Rollins S, Goloubeva O, Morales RE, Tan M, Taylor R, Wolf JS, Schumaker LM, Cullen KJ, Zimrin A, Ord R, Lubek JE, Suntharalingam M, Papadimitriou JC, Mann D, Strome SE, Edelman MJ.

Cancer Immunol Immunother. 2015 Mar;64(3):367-79. doi: 10.1007/s00262-014-1640-x. Epub 2014 Dec 24.

6.

Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.

Zandberg DP, Liu S, Goloubeva O, Ord R, Strome SE, Suntharalingam M, Taylor R, Morales RE, Wolf JS, Zimrin A, Lubek JE, Schumaker LM, Cullen KJ.

Head Neck. 2016 Apr;38(4):564-72. doi: 10.1002/hed.23933. Epub 2015 Jun 30.

7.

Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007.

Zandberg DP, Liu S, Goloubeva OG, Schumaker LM, Cullen KJ.

Cancer Prev Res (Phila). 2015 Jan;8(1):12-9. doi: 10.1158/1940-6207.CAPR-14-0089-T. Epub 2014 Jun 10.

8.

Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.

Wu Y, Posner MR, Schumaker LM, Nikitakis N, Goloubeva O, Tan M, Lu C, Iqbal S, Lorch J, Sarlis NJ, Haddad RI, Cullen KJ.

Cancer. 2012 Apr 1;118(7):1811-7. doi: 10.1002/cncr.26485. Epub 2011 Aug 25.

9.

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker LM, Sarlis NJ, Haddad RI, Cullen KJ.

Ann Oncol. 2011 May;22(5):1071-7. doi: 10.1093/annonc/mdr006. Epub 2011 Feb 11.

10.

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.

Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, Strome SE, Haddad RI, Patel SS, Cambell EV 3rd, Sarlis N, Lorch J, Cullen KJ.

Cancer Prev Res (Phila). 2009 Sep;2(9):776-81. doi: 10.1158/1940-6207.CAPR-09-0149. Epub 2009 Jul 29.

12.

Estrogen receptor expression and sensitivity to paclitaxel in breast cancer.

Dougherty MK, Schumaker LM, Jordan VC, Welshons WV, Curran EM, Ellis MJ, El-Ashry D.

Cancer Biol Ther. 2004 May;3(5):460-7. Epub 2004 May 18.

PMID:
15020841
13.

Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.

Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR.

Cancer Res. 2003 Dec 1;63(23):8097-102.

14.

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

Rudin CM, Yang Z, Schumaker LM, VanderWeele DJ, Newkirk K, Egorin MJ, Zuhowski EG, Cullen KJ.

Cancer Res. 2003 Jan 15;63(2):312-8.

15.

Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?

DaCosta SA, Schumaker LM, Ellis MJ.

J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):85-94. Review.

PMID:
10791771
16.

The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.

Oates AJ, Schumaker LM, Jenkins SB, Pearce AA, DaCosta SA, Arun B, Ellis MJ.

Breast Cancer Res Treat. 1998 Feb;47(3):269-81. Review.

PMID:
9516081
17.

The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor.

Shabahang M, Buffan AE, Nolla JM, Schumaker LM, Brenner RV, Buras RR, Nauta RJ, Evans SR.

Ann Surg Oncol. 1996 Mar;3(2):144-9.

PMID:
8646514
18.

Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.

Davoodi F, Brenner RV, Evans SR, Schumaker LM, Shabahang M, Nauta RJ, Buras RR.

J Steroid Biochem Mol Biol. 1995 Aug;54(3-4):147-53.

PMID:
7662588
19.

The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.

Brenner RV, Shabahang M, Schumaker LM, Nauta RJ, Uskokovic MR, Evans SR, Buras RR.

Cancer Lett. 1995 May 25;92(1):77-82.

PMID:
7757962
20.

The effect of extracellular calcium on colonocytes: evidence for differential responsiveness based upon degree of cell differentiation.

Buras RR, Shabahang M, Davoodi F, Schumaker LM, Cullen KJ, Byers S, Nauta RJ, Evans SR.

Cell Prolif. 1995 Apr;28(4):245-62.

PMID:
7772641
21.

Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.

Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR.

Cancer Res. 1994 Aug 1;54(15):4057-64.

22.

Vitamin D receptors in breast cancer cells.

Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR.

Breast Cancer Res Treat. 1994;31(2-3):191-202.

PMID:
7881099
23.

1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.

Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR.

Cancer Res. 1993 Aug 15;53(16):3712-8.

Supplemental Content

Loading ...
Support Center